In addition, remuneration for research for health staff should be prioritized and their career development paths clearly elaborated.
It is not a quantum leap to suggest that if functionality of body organs is so valued and remuneration for research on the living body permitted, the worth of body organs (just like land and other acquired assets), should be allowed, after death, to pass to relatives or any other beneficiaries nominated by the deceased in a will.
The practice site recruitment rate varies between 25% (Japan and China) and 40% (e.g., U.S., Mexico, Saudi Arabia) at present, with the primary reasons for non-participation being conduct of competing studies, lack of interest in observational research, lack of personnel, perception that remuneration for observational research is too low, and concerns regarding the number of questionnaires.
A major limitation is the selection of patient groups based on diagnoses set by GPs in the routine data used for remuneration purposes and not for research.
A report in the Daily Nation, (tinyurl.com/62qq3m) quoted them as saying a low ranking was deserved due to "lack of support for research, poor remuneration, insufficient resources and poor management".
It seems to be a need for increased funding for research, better education and remuneration by the Statutory Health Insurance in order to improve access to 'Integrative medicine' in Germany.
Participants received $20 remuneration for their contribution to the research, as well as referrals to medical and social services as appropriate.
Recruitment of GPs for research studies is often challenging due to GPs' time constraints, lack of remuneration and workforce shortages.
HJ: honoraria from Sanofi-Aventis; TA: honoraria and research funding from Eli Lilly; TT-H: remuneration for travelling; ML: employee of 4Pharma Ltd.; MH-K, employee of Eli Lilly, stock ownership of Eli Lilly & Co. PK-LL: honoraria, research funding and other remuneration from Sanofi-Aventis, Roche and Pfizer.
A.M.G. has research funding from AstraZeneca, Pfizer and Genentech, and has received remuneration for giving talks at Pfizer and Genentech.
Only 11.6%% of the patients (n = 1918) would be influenced in favor of taking part in research studies if they were to receive financial remuneration for it (Table 5).
